SCHEMBL6276227

SCHEMBL6276227

CC(=O)OCCOc1ccc2c(O)c(OC/C=C(\C)CCC=C(C)C)c(=O)oc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.54
▸ MAOA P21397 1/20 0.54
▸ ALOX15 P16050 8/20 0.52
▸ TDP1 Q9NUW8 4/20 0.52
▸ CYP3A4 P08684 3/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ HPGD P15428 3/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ NDUFS8 O00217 1/20 0.52
▸ COXFA4 O00483 1/20 0.52
▸ NDUFAB1 O14561 1/20 0.52
▸ NDUFA1 O15239 1/20 0.52
▸ NDUFS4 O43181 1/20 0.52
▸ NDUFB5 O43674 1/20 0.52
▸ NDUFB3 O43676 1/20 0.52
▸ NDUFC1 O43677 1/20 0.52
▸ NDUFA2 O43678 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6276230 1.00 MAOB (0.54) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL6275880 0.93 MAOB (0.54) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL6275873 0.93 MAOB (0.54) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL8490417 0.91 ALOX15 (0.62) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL6274714 0.90 MAOB (0.53) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL6274707 0.90 MAOB (0.53) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL6277116 0.90 ALOX15 (0.54) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL6277123 0.90 ALOX15 (0.54) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL6276850 0.89 ALOX15 (0.53) MAOBMAOAALOX15TDP1CYP3A4
SCHEMBL6276857 0.89 ALOX15 (0.53) MAOBMAOAALOX15TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 MAOB 1155/4885MAOA 665/4885ALOX15 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback